Inflammation O O O O
and O O O O
Immune O O O O
Systems O O O O
Bioengineering O O O O
Lab O O O O
One Reason 3 O O
critical Reason 3 O O
challenge Reason 3 O O
in Reason 3 O O
modern Reason 3 O O
medicine Reason 3 O O
lies Reason 3 O O
in Reason 3 O O
understanding Reason 3 O O
how Reason 3 O O
disease Reason 3 O O
differentially Reason 3 O O
impacts Reason 3 O O
individuals Reason 3 O O
based Reason 3 O O
on Reason 3 O O
personalized Reason 3 O O
genetic Reason 3 O O
and Reason 3 O O
environmental Reason 3 O O
factors. Reason 3 O O
The O O O O
Arnold O O O O
Lab O O O O
uses O O O O
systems O O O O
engineering O O O O
approaches O O O O
to O O O O
understand O O O O
variability O O O O
in O O O O
the O O O O
immune O O O O
response O O O O
to O O O O
infection, O O O O
vaccination, O O O O
and O O O O
injury. O O O O
Computational O O O O
approaches O O O O
developed O O O O
in O O O O
our O O O O
laboratory O O O O
give O O O O
new O O O O
insight O O O O
into O O O O
mechanism O O O O
and O O O O
provide O O O O
better O O O O
classification O O O O
of O O O O
disease O O O O
states. O O O O
Current O O O O
projects O O O O
in O O O O
the O O O O
lab O O O O
focus O O O O
on: O O O O
1) Reason 4 O O
gaining Reason 4 O O
insights Reason 4 O O
into Reason 4 O O
how Reason 4 O O
personalized Reason 4 O O
differences Reason 4 O O
in Reason 4 O O
antibody Reason 4 O O
features Reason 4 O O
influence Reason 4 O O
the Reason 4 O O
immune Reason 4 O O
response Reason 4 O O
after Reason 4 O O
vaccination; Reason 4 O O
2) O O O O
understanding O O O O
how O O O O
variability O O O O
in O O O O
the O O O O
composition O O O O
of O O O O
the O O O O
vaginal O O O O
microbiome O O O O
impacts O O O O
disease O O O O
susceptibility O O O O
and O O O O
therapeutic O O O O
efficacy O O O O
in O O O O
women; O O O O
and O O O O
3) O O O O
identifying O O O O
immune O O O O
signatures O O O O
associated O O O O
with O O O O
exacerbation O O O O
and O O O O
progression O O O O
of O O O O
chronic O O O O
lung O O O O
diseases O O O O
